OptimizeRx Corporation OPRX
6.94 USD +0.30 (+4.52%)
Regular-session close
7.07 +0.13 +1.87%
After hours · Nov 17, 4:40 PM ET
6.61 Day range 7.03
4.54 52-week range 15.59
- YTD
- -43.39%
- 1 year
- -53.08%
Benzinga news
benzinga.com Lake Street Maintains Buy on OptimizeRx, Lowers Price Target to $10 Lake Street analyst Eric Martinuzzi maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $11 to $10.
benzinga.com These Analysts Cut Their Forecasts On OptimizeRx After Q3 Results OptimizeRx beat Q3 earnings and sales estimates but cut FY2026 revenue guidance; shares fell 17.3% as analysts lowered price targets.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Addex Therapeutics (NASDAQ:ADXN) stock moved upwards by 73.5% to $5.01 during Thursday's regular session. enGene Therapeutics (NASDAQ:ENGN) stock rose 29.37% to $2.33. The company's market…benzinga.com B. Riley Securities Reiterates Buy on OptimizeRx, Lowers Price Target to $10.5 B. Riley Securities analyst Josh Nichols reiterates OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $11 to $10.5.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Addex Therapeutics (NASDAQ:ADXN) stock rose 74.0% to $5.03 during Thursday's pre-market session. ZeroStack (NASDAQ:ZSTK) stock increased by 11.56% to $2.99. The market value of their…benzinga.com Stifel Maintains Buy on OptimizeRx, Lowers Price Target to $11 Stifel analyst David Grossman maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $12 to $11.
benzinga.com Why Tetra Tech Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket Tetra Tech shares jumped 8.5% after beating Q4 estimates; Children's Place surged 302%, while Wheeler REIT fell 35.3% premarket.
benzinga.com OptimizeRx Shares Tumble 20% After-Hours: Here's Why OptimizeRx shares tumble 20% after-hours after earnings beat estimates despite lower 2026 revenue guidance.
benzinga.com OptimizeRx Q3 2026 Earnings Call Transcript OptimizeRx (NASDAQ:OPRX) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Can Fite Biopharma (AMEX:CANF) stock rose 7.1% to $1.66 during Wednesday's after-market session. The market value of their outstanding shares is at $3.5 million. iTonic Holdings (NASDAQ:ITOC)…benzinga.com OptimizeRx Q3 Adj. EPS $0.20 Beats $0.17 Estimate, Sales $21.615M Beat $21.188M Estimate OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.17 by 17.65 percent. This is unchanged from the same period last year. The…
benzinga.com OptimizeRx Lowers FY2026 Sales Guidance from $95.000M-$100.000M to $87.000M-$93.000M vs $96.230M Est OptimizeRx (NASDAQ:OPRX) lowers FY2026 sales outlook from $95.000 million-$100.000 million to $87.000 million-$93.000 million vs $96.230 million estimate.
